INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission
INO-3107 is an investigational DNA medicine candidate designed to elicit a targeted T cell response against HPV-6 and…